Xconomy | National - Business + Technology in the Exponential Economy

Archives

by in
Entry Blogger Date Location
Combination Drugs Are The Future for Hepatitis C Steve Worland 11/03/09 San Diego
UW Scientists, Backed by Gates Foundation, Enter “Put Up or Shut Up” Phase with Portable Diagnostic Luke Timmerman 11/03/09 Seattle
Virdante Pharma Lands $30M in A Round to Combat Inflammation Ryan McBride 10/29/09 Boston
Vertex Hepatitis C Drug Wipes Out Virus For Toughest-to-Treat Patients Luke Timmerman 10/28/09 Boston
San Diego’s Ardea Biosciences Sees Potential for Gout Drug in Combination Treatment Denise Gellene 10/19/09 San Diego
Omeros Accused on Eve of IPO, Seattle Genetics Trial Fails, How Much Biotechies Really Earn, & More Seattle-Area Life Sciences News Luke Timmerman 10/08/09 Seattle
Seattle’s Theraclone Strikes $18M Deal to Make Flu-Fighting Antibodies with Japanese Company Luke Timmerman 10/05/09 Seattle
AVI Settles In, ZymoGenetics MS Drug Fails, Dendreon’s FDA Filing Set for Mid-November & More Seattle-Area Life Sciences News Luke Timmerman 10/01/09 Seattle
The Quest for an HIV Vaccine Lawrence Corey 09/29/09 Seattle
Targeted Genetics Lives On, CellCyte Charged With Fraud, Theraclone Finds HIV Weakness, & More Seattle-Area Life Sciences News Luke Timmerman 09/10/09 Seattle
Daktari Diagnostics Closes $2.8M Series A Round to Combat Global HIV Crisis Ryan McBride 09/04/09 Boston
Finding HIV’s Weak Spot, Scientists at Seattle’s Theraclone and San Diego’s Scripps See Opening for New Vaccine Luke Timmerman 09/03/09 National
Targeted Genetics Dumps Lease, Amgen’s Dmab Works in Cancer Trial, Theraclone Nabs Cash, & More Seattle-Area Life Sciences News Luke Timmerman 07/09/09 Seattle
Theraclone Gets Funding for HIV Luke Timmerman 07/06/09 Seattle
Cell Therapeutics Ships App to FDA, Targeted Genetics Cuts Again, Sanofi CEO Looks to Biotech & More Seattle Area Life Sciences News Luke Timmerman 06/25/09 Seattle
Amnis Rolls Out Souped Up Scientific Tool, Just as Customers Start Feeling Flush Luke Timmerman 06/24/09 Seattle
Global Health Funding Booms, But Not Just From Gates, UW-Harvard Study Finds Luke Timmerman 06/18/09 Seattle
HIV’s “Tireless Warrior,” Anthony Fauci, Calls for Transformation of TB Research Luke Timmerman 06/18/09 Seattle
Concert Pharma Jamming with Glaxo in Deal with $1B-Plus Potential Ryan McBride 06/02/09 Boston
Targeted Genetics, Mainstay of Gene Therapy, Faces Likely Shutdown Luke Timmerman 05/07/09 Seattle
NewPath Picks Up $30M, Asemblon Raises $2.9M, Amazon Buys Lexcycle, & More Seattle-Area Deals News Gregory T. Huang 04/28/09 Seattle
PATH Gets $52M for HIV Work Luke Timmerman 04/24/09 Seattle
Anadys Hepatitis C Drug Shows Potent Effect in Small Study Luke Timmerman 04/23/09 San Diego
Amylin Braces to Battle Carl Icahn, Calit2’s Network for Institutional Innovation, Sangart Ponders Its Next Move, & More San Diego BizTech News Bruce V. Bigelow 04/13/09 San Diego
Dendreon Saga Nears Climax, Gregoire Biotech Fund in Jeopardy, UW’s Biofuel Futurist, & More Seattle-Area Life Sciences News Luke Timmerman 04/09/09 Seattle
Ardea Biosciences, in Moment of Serendipity, Discovers HIV Drug That May Work for Gout Luke Timmerman 04/08/09 San Diego
Antibodies for HIV, Long Dismissed, Show Signs of Comeback at Seattle’s Theraclone Luke Timmerman 04/07/09 Seattle
UW’s Protein Guru, David Baker, Eyes Alternative Biofuels, Vaccines in New 3-D Structures Luke Timmerman 04/02/09 Seattle
Genzyme Enters Seattle Hub, Oncothyreon Bets on Cancer Drugs, Pathway Nabs $40M, & More Seattle-Area Life Sciences News Luke Timmerman 04/02/09 Seattle
Genzyme Gene Therapy Fails To Help People with Leg Disease Walk Longer Luke Timmerman 03/31/09 Boston
Page 1 of 3 next page »
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2009, Xconomy, Inc. XCONOMY is a registered service mark of Xconomy, Inc. All rights reserved.
Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.